Izifundo zibonisa ukungafani kweziphumo ze-osteoarthritis kunye nesifo se-rheumatoid arthritis.
Ngaba ukutya kwakho kwaneleyo kwizityalo kunye nemifuno ecebileyo kwi-vitamin C? Ngaba kufuneka uthabathe i-vitamin C ? Ngaba kukho ubudlelwane okanye ukhuselo phakathi kwevithamini C kunye ne-arthritis? Ezi zinto zibalulekileyo ezifunekayo.
I-Vitamin C kunye neArthritis
Olunye uphando lubonisa ukuba i-vitamin C ikhusela isifo se-arthritis kwaye ikhusela iimpawu xa omnye uphando lubonisa ukuba i-vitamin C ingabangela ukonakala kwesifo se-arthritis.
Kutheni ukungafani? Kukho ngokwenene isizathu. Ezi zifundo zijoliswe kwiintlobo ezimbini ezahlukeneyo zesifo se-arthritis , i- rheumatoid arthritis (RA) kunye ne- osteoarthritis (OA), ezo iinkqubo ezahlukeneyo zezifo.
I-Vitamin C ne-Osteoarthritis
I-osteoarthritis ibonakaliswe ukuwohloka kokuhamba kwamalungu, isizathu sokuba kuthethwa njengolu hlobo lwe-arthritis. Iziphumo zoFundo, ezivela kumxholo we- Arthritis & Rheumatism , ngoJuni 2004, zibonise ukuba ukusetyenziswa kwexesha elide kwe-vitamin C kunokudambisa ubunzima be- osteoarthritis yamadolo .
Abaphandi bahlalutya umphumo weenyanga ezisibhozo zezilwanyana eziphantsi, eziphakathi kunye neziphakamileyo zevithamini C kwiibhagi zaseginea. Iigogo zeGuinea, njengabantu, abakwazi ukuvelisa i-vitamin C ngokwabo.
Iqela leqondo eliphezulu lenze i- osteoarthritis enamandla kakhulu emadolweni kunye nomonakalo omkhulu kakhulu we-cartilage. Abaphandi kulolu cwaningo baphetha ukuba ukutya okudliwayo kwe-vitamin C akufaneleki ukuxhaswa ngaphezu kwesibonelelo sokutya esicetywayo sangoku:
- 90 mg ngosuku ngamadoda.
- 75 mg. ngemini yabasetyhini.
I-Vitamin C kunye ne-Rheumatoid Arthritis
I-rheumatoid arthritis yisifo esisigxina esisisigxina esibangela ukuvuvukala kwimbumba yamalungu, okubangele ukutshabalalisa nokubola kweelungu elichaphazelekayo. Kuye kwabikwa kwi- Annal ye-Rheumatic Diseases , ukuba ukutya kokutya okuphezulu kwi-vitamin C kubonakala kukukhusela ekuchaseni i- polyarthritis , uhlobo lwe-rheumatoid arthritis olubandakanya amabini amabini okanye amaninzi.
Olu pho nonongo lwabandakanya abathathi-nxaxheba abangaphezu kwama-23,000 abaye bangena kwisifundo esikhulu somdlavuza e-UK Abathathi-nxaxheba babegcina idayari zokutya kwaye babekho i-arthritis-free in the study.
Abaphandi baqhathanisa izidlo zabathathi-nxaxheba abangama-73 abaye bahlambalaza i-polyarthritis ngexesha leminyaka elinesibhozo kunye no-146 abahlala be-arthritis. Emva kokuhlalutya, abaphandi baphetha ngelithi abantu ababa ne-arthritis badla izityalo kunye nemifuno embalwa kunabo abazange babe nesifo. Abathathi-nxaxheba abadla izityalo ezincinci kunye nemifuno babenomngcipheko wokuba ne- arthritis evuthayo kabini.
Kwakukho umehluko omkhulu kumntu obuninzi be-vitamin C abane-arthritis abadlayo xa kuthelekiswa nalabo abangazange bahlakulele isifo samathambo. Abathathi-nxaxheba abasebenzisa ixabiso elincinci le-vitamin C babephindwe kathathu amathuba okuba bahlakulele imeko ye-arthritic kunezo zidla ixabiso eliphezulu le-vitamin C. Imiphumo emihle ye-vitamin C kwi-arthritis ye-rheumatoyi ingaba ngenxa yokuba:
- I-Vitamin C yintsholongwane enamandla yokulwa ne- antioxidant , i-molecule elwa ne-inflammation ye-rheumatoid.
- I-Vitamin C isebenze indima njenge-cofactor kwi-collagen synthesis, iprotheyini ephambili kwiimpawu ezihlangeneyo kunye namathambo.
- I-Vitamin C inendima ekulwa nokusuleleka kwaye inokusebenza ukulawula ukuvutha okuxhomekeke kwintsholongwane.
- Abanye bakholelwa ukuba ukusuleleka kunokususa iirharensi zesifo se-rheumatoid.
Isiphelo
Ukumodareyitha kwi-vitamin C isiluleko sinokucetyiswa ukuba kugcinwe amathambo kunye namalungu aphilileyo. Ukutya okugqithiseleyo kwe-vitamin C kungabangela ingxaki. Ukutya iziqhamo kunye nemifuno ukufumana imihla ngemihla i-vitamin C ekhuthazwa ngokwemvelo.
Imithombo:
I-Vitamin C I-Worsens Knee Osteoarthritis kwi-Animal Study, iDuke University Medical Centre. 6/3/2004.
I-Vitamin C kunye nomngcipheko wokuphuhlisa i-polyarthritis: ukufundwa kwetyala lokulawulwa kwetyala, i-Annals ye-Rheumatic Diseases, ngo-2004: 63: 843-847.Onard.bmj.com/content/63/7/843